Among them, age, tumor site, histological grade, tumor size, estrogen receptor (ER) status, progesterone receptor (PR) status, the number of SLNs, and whether or not chemotherapy had statistical significance (P < .05). The gene discussed is ESR1; the disease is neoplasm.